Semaglutide: Difference between revisions
From Pharmacopedia
More actions
| [checked revision] | [checked revision] |
MDElliottMD (talk | contribs) Migrate <indication> tags to <problem> (Phase 2 of indications-to-problems rebuild) |
MDElliottMD (talk | contribs) Sweep: "indications" -> "problems" sitewide terminology update (preserves MedTemplate param name) |
||
| Line 90: | Line 90: | ||
Importantly: semaglutide is '''not a contraceptive''', and the medicine may '''restore ovulation''' in patients with [[PCOS]] or [[obesity]]-associated anovulation.{{Citation needed}} Patients of childbearing potential should be counseled about contraception ''before'' starting. | Importantly: semaglutide is '''not a contraceptive''', and the medicine may '''restore ovulation''' in patients with [[PCOS]] or [[obesity]]-associated anovulation.{{Citation needed}} Patients of childbearing potential should be counseled about contraception ''before'' starting. | ||
| monitoring = * Baseline: HbA1c, weight, BP, renal function, lipid panel, [[ALT]]/AST (especially for MASH | | monitoring = * Baseline: HbA1c, weight, BP, renal function, lipid panel, [[ALT]]/AST (especially for MASH problem) | ||
* Personal or family history of MTC or [[MEN2]] — '''contraindicated''', do not start<ref name="ozempic-label"/> | * Personal or family history of MTC or [[MEN2]] — '''contraindicated''', do not start<ref name="ozempic-label"/> | ||
* Every 3 months for first year: HbA1c, weight, GI tolerability, signs of [[pancreatitis]] or [[gallbladder disease]] | * Every 3 months for first year: HbA1c, weight, GI tolerability, signs of [[pancreatitis]] or [[gallbladder disease]] | ||